Pelvic Organ Prolapse Repair Market Analysis

  • Report ID: 5424
  • Published Date: Nov 30, 2023
  • Report Format: PDF, PPT

Pelvic Organ Prolapse Repair Market Analysis

Treatment Type (Surgical, Non-Surgical)

The non-surgical segment in the pelvic organ prolapse repair market is estimated to gain a robust revenue share of 68% in the coming years. A pessary fitting is usually the non-surgical treatment for Pelvic Organ Prolapse (POP) that frequently involves the use of a support device known as a "pessary” which is a detachable device that offers support following a prolapse by generating a useful blockage inside the vagina that occurs when the vaginal or uterine walls weaken, which can happen with age or after giving birth.

Additionally, women who experience pelvic organ prolapse also have the option of receiving pelvic floor physical therapy that involves a number of exercises designed to strengthen and relax the pelvic muscles which can be used to help the muscles perform properly and reduce the symptoms of pelvic floor dysfunction and can assist with incontinence, uncomfortable sex, and trouble with bladder or bowel motions. For instance, Kegel exercises also termed pelvic floor muscle training, improve the pelvic floor muscles by first tightening and then relaxing them and are also capable of treating other pelvic floor issues and for overactive bladder treatment. Moreover, The effectiveness of Kegel exercises in treating stress incontinence in women ranges from around 25% to 85%. Besides this, pelvic organ prolapse can be effectively repaired with reconstructive surgery, which also repairs damage from endometriosis, uterine prolapse, and urine incontinence.

Application (Cystocele, Uterine Prolapse, Rectocele, Enterocele, Posterior Vaginal Wall Prolapse)

The uterine prolapse segment in the pelvic organ prolapse repair market is set to garner a notable share of 41% shortly. Weakness of the pelvic muscles and tissue leads to uterine prolapse which is a common ailment that can develop with age whereby the uterus may begin to droop out of position depending on the severity of the prolapse. there are surgical and nonsurgical treatments for treating uterine prolapse such as minimally invasive procedures, sometimes known as vaginal or laparoscopic procedures can be performed to strengthen pelvic floor muscles, and Kegel exercises can better support the pelvic organs and may provide relief from uterine prolapse symptoms.

Furthermore, the cystocele segment is anticipated to garner a noteworthy share. Anterior vaginal prolapse, also known as a cystocele, is a disorder in which the tissues supporting the bladder and vaginal wall weaken and stretch and in extreme circumstances, the prolapsed bladder may become visible at the vaginal opening the treatment of which may require surgery or pelvic floor muscle strengthening.

Our in-depth analysis of the global market includes the following segments:

          Treatment Type

  • Surgical
  • Non-Surgical

          Application

  • Cystocele
  • Uterine Prolapse
  • Rectocele
  • Enterocele
  • Posterior Vaginal Wall Prolapse

          End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinic

          Product Type

  • Vaginal Pessary
  • Vaginal Mesh

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5424
  • Published Date: Nov 30, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of pelvic organ prolapse (POP) in the female population across the globe and the growing development of advanced and new pelvic organ prolapse repair devices are the major factors driving the growth of the market.

The market size of pelvic organ prolapse repair is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2024-2036.

The major players in the market are CooperSurgical, Inc., Dr. Arabin GmbH & Co. KG, Integra LifeSciences, Utah Medical Products, Inc., Shenzhen XFT Medical Limited, Sunmedix Co, Ltd., Verity Medical Ltd, Neomedic, and Johnson & Johnson Services, Inc., Coloplast Pty Ltd, Boston Scientific Corporation, and others.

The non-surgical segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying